The 221b Foundation Grants License to ALBOT Technologies to Develop, Manufacture and Distribute CRISPR COVID-19 Diagnostic Kits in India

Sherlock™ CRISPR SARS-CoV-2 Kit to be Distributed Across Government Labs and Facilities to Meet Diagnostic Testing Needs Across the Region BOSTON, June 15, 2021 – The 221b Foundation, a nonprofit organization established by Sherlock Biosciences to address the global COVID-19 pandemic while promoting diverse representation in STEM, today announced that it has granted a licenseContinue reading “The 221b Foundation Grants License to ALBOT Technologies to Develop, Manufacture and Distribute CRISPR COVID-19 Diagnostic Kits in India”

The 221b Foundation Grants Licenses to Multiple Organizations to Develop and Distribute CRISPR COVID-19 Diagnostic Kits Globally

Cooper International and United PPE to Produce Kits for Worldwide Distribution of Sherlock’s CRISPR Technology as Part of Ongoing Testing Strategies BOSTON, April 21, 2021 – The 221b Foundation, a nonprofit organization established by Sherlock Biosciences to address the global COVID-19 pandemic while promoting diverse representation in STEM, today announced that it has granted CooperContinue reading “The 221b Foundation Grants Licenses to Multiple Organizations to Develop and Distribute CRISPR COVID-19 Diagnostic Kits Globally”

The 221b Foundation Establishes Coalition to Control the Spread of COVID-19 in Nepal

Sherlock™ CRISPR SARS-CoV-2 Kit Designated as Essential Diagnostic Test for Nepal’s National Testing Strategy Cambridge, Mass., January 6, 2021 – The 221b Foundation, a nonprofit organization established by Sherlock Biosciences to address the global COVID-19 pandemic and diverse representation in STEM, today announced an initiative with the Ministry of Health and Population (MoHP) in NepalContinue reading “The 221b Foundation Establishes Coalition to Control the Spread of COVID-19 in Nepal”